Search Results
Results found for "Brian Matthews"
- Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment ...
treatment of neuropathic pain, a debilitating condition caused by damage to the nerves outside of the brain
- Decoding β-Arrestins: from Structure to function
distinct GPCR phosphorylation patterns, which influence their conformational states and functions (Matthees role in determining the formation of protein complexes and their functions within specific tissues (Matthees
- A2B Adenosine Receptor Enhances Chemoresistance of Glioblastoma Stem-Like Cells under Hypoxia: New..
New Insights into MRP3 Transporter Function "Glioblastoma is the most common and aggressive primary brain
- Design and validation of recombinant protein standards for quantitative Western blot analysis of...
quantitative Western blot analysis of CB1 receptor expression on crude synaptosomes of the adult rat brain
- Signaling pathways activated by sea bass gonadotropin-inhibitory hormone peptides in COS-7 cells...
GnIH) system in the European sea bass, Dicentrarchus labrax, which exerted an inhibitory action on the brain-pituitary-gonadal
- GPCR voltage dependence controls neuronal plasticity and behavior
G-protein coupled receptors (GPCRs) play a paramount role in diverse brain functions.
- Increased Anxiety-like Behaviors in Adgra1-/- Male But Not Female Mice are Attributable to...
We found that Adgra1 is highly and exclusively expressed in the brain, suggesting that Adgra1 may be
- Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice
However, the pharmacokinetic properties of DOI differed among sexes - brain and plasma concentrations
- Advantages of Fluorescent Probes in GPCR Assays
Sridharan R, Zuber J, Connelly SM, Mathew E, Dumont ME.
- Co-activation of GPCRs facilitate GIRK-dependent current
Recordings in brain slices have shown that co-activation using saturating concentrations of agonists
- β-arrestin1 promotes tauopathy by transducing GPCR signaling, disrupting microtubules and autophagy
and mGluR2-mediated increase in pathogenic tau but also show that β-arrestin1 levels are increased in brains
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
you with the kinetic models and biological context needed to design drugs that actually work where it matters In structured, diffusion-restricted environments (e.g. brain, tumors), drugs don't just leave slowly;
- Asking Better Questions in Science: A Practical Guide for Emerging Researchers
I’m running into a problem and I know you work on something similar — can I pick your brain for one minute
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
CB1R are mainly found in the central nervous system (CNS) and the brain.
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
shows data from risperidone, comparing offset rates in open compartments vs. restricted ones like the brain Same Affinity, Different Outcomes: Why Residence Time Matters More Two ligands.
- Scientific Isolation: The Real Reason Early Biotechs Lose Traction
company mantra Investor communication feels reactive and apologetic Key documents live in the CEO’s brain It causes a slow erosion of everything that matters. 1️⃣ External Trust Collapses Quietly Investors requires: A crisp BD trajectory that evolves every quarter A 1–2 page positioning document (“Why This Matters
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Metabolic Disease and GLP-1 After his PhD, Hodson entered neuroendocrinology — the “interface” between brain Sometimes the experiments you almost quit are the ones that matter most. Why it matters: Personalizing care depends on understanding biological variability. Why it matters: Muscle mass shapes longevity, resilience, and overall metabolic health. Why it matters: Cell-specific delivery reduces off-target effects and boosts efficacy.
- 📰 GPCR Weekly News, October 9 to 15, 2023
Mouse Models of Social Interaction and Cognitive Impairment GPCRs in Neuroscience The Drosophila blood-brain
- 📰 GPCR Weekly News, April 17 to 23, 2023
Bryan Roth, Sudarshan Rajagopal, and Graeme Milligan. Save the date! Dr.
- 📰 GPCR Weekly News, October 23 to 29, 2023
Neuroscience Dopaminergic Input Regulates the Sensitivity of Indirect Pathway Striatal Spiny Neurons to Brain-Derived
- 📰 GPCR Weekly News, May 22 to 28, 2023
Bryan Roth, Peter Gmeiner, and Thomas P. Sakmar this week. For Dr.
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Bryan Roth's work on "Built-in functional selectivity in neurons is mediated by the neuronal protein,
- 📰 GPCR Weekly News, December 4 to 10, 2023
Bryan L Roth study on Illuminating the understudied GPCR-ome Save the dates: February 8 - 29: Dr.
- 📰 GPCR Weekly News, February 13 to 19, 2023
Understanding Neuropeptide Transmission in the Brain by Optical Uncaging and Release.
- Therapeutic validation of an orphan G protein‐coupled receptor
GPR84 is a Gi‐coupled class A GPCR mainly expressed in immune cells and microglia in the brain (Wojciechowicz
- VAMP2: a crucial player in the delivery of MOR to the synapse
essential for developing new treatments for these disorders and advancing our understanding of the brain
- 📰 GPCR Weekly News, June 26 to July 2, 2023
History and function of the lactate receptor GPR81/HCAR1 in the brain: a putative therapeutic target
- 📰 GPCR Weekly News, February 27 to March 5, 2023
GPCRs in Neuroscience Physiological Condition Dependent Changes in Ciliary GPCR Localization in the Brain
- 📰 GPCR Weekly News, April 22 to 28, 2024
INSL5 chimeric peptide ligand for NanoBiT complementation binding assays Generation of a deep mouse brain
- 📰 GPCR Weekly News, March 13 to 19, 2023
GPCRs in Neuroscience Physiological Condition-Dependent Changes in Ciliary GPCR Localization in the Brain








